A detailed history of Gamma Investing LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 184 shares of RLAY stock, worth $778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184
Previous 43 327.91%
Holding current value
$778
Previous $280,000 365.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$6.23 - $9.51 $878 - $1,340
141 Added 327.91%
184 $1.3 Million
Q2 2024

Jul 02, 2024

SELL
$5.9 - $8.02 $814 - $1,106
-138 Reduced 76.24%
43 $280,000
Q1 2024

Apr 05, 2024

SELL
$7.5 - $12.07 $1,410 - $2,269
-188 Reduced 50.95%
181 $1.5 Million
Q4 2023

Feb 01, 2024

BUY
$6.01 - $11.48 $2,217 - $4,236
369 New
369 $3.41 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.